Skip to main content

MIT Corporate Relations

MIT Corporate Relations
MIT Logo
  • Events
  • STEX25
  • Startups
  • opportunities
  • MIT ILP
  • Sign-In
  • Register Your Startup
  • Search
STEX Home
  • Events
    • Corporates
    • Event Videos
    • Startups
  • STEX25
    • Featured
    • Videos
  • Startups
    • Search
    • News
  • opportunities
  • MIT ILP
User Menu and Search
  • Sign-In
  • Register Your Startup
STEX Home
Toggle menu
  • Sign-in
  • Register your startup
  • Events
    • Corporates
    • Event Videos
    • Startups
  • STEX25
    • Featured
    • Videos
  • Startups
    • Search
    • News
  • opportunities
  • MIT ILP

Search Results


Filter Results
Staff

Filter Results

Narrow your search results
  • News (16)
  • Videos (43)
  • Events (6)
  • Startup Opportunities (22)
  • Startups
  • Founders
Please sign-in to see the full search results
105 search results found
  • Tumor invasiveness
    October 21, 2019 | MIT News Office

    Cell stiffness may indicate whether tumors will invade

  • Tzouanas
    August 17, 2023 | MIT News Office

    How the body’s cells work together in response to infection

  • April 18, 2025 | MIT News Office

    Equipping living cells with logic gates to fight cancer

  • AI solar
    June 5, 2019 | MIT News Office

    How to speed up the discovery of new solar cell materials

  • Optical pooled screens
    October 17, 2019 | MIT News Office

    Imaging combined with genetic screening of cells enhances genomic discoveries

  • Cellino Biotech, Inc.

    Cambridge, MA
    Biotechnology
    Cellino has built the first platform that enables precise control over iPS cell fate in their natural environment. Their proprietary delivery technology, NanoLaze, delivers synthetic biology tools to control the sequence of genes being turned on and off inside a cell. This offers precise, “digital”... More
    Cellino_color
  • Kytopen Corporation

    Cambridge, MA
    Biotechnology
    Kytopen is developing platforms to accelerate the discovery and manufacturing of next-generation cell & gene therapies. The Flowfect technology offers a scalable, non-viral solution to deliver genetic payloads to cells in order to augment their functionality. The technology also enables continuous... More
    Keywords:
    Flowfect(R), Non-Viral, Gene Editing, CRISPR delivery, Continuous Processing, cell therapy, Genome Engineering, CAR T-cells, Engineered TCR T-cells
    Kytopen
  • Melt electrowriting
    March 25, 2019 | MIT News Office

    New 3-D printing approach makes cell-scale lattice structures

  • Past Deadline: Mar 15, 2025

    MIT Health Forum presentation opportunity for startups

    speaker

     MIT Startup Exchange will select 4 startups to present and exhibit at the 2025 MIT Health & Science Forum on May 8.

  • Cracking Cancer 2.0 - Lightning Talks

    Cracking Cancer 2.0 - Lightning Talks

    December 7, 2017 | Startup Exchange Video | Duration: 30:6

    Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.

Pagination

  • of 9
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next page
  • Events
    • Corporates
    • Event Videos
    • Startups
  • STEX25
    • Featured
    • Videos
  • Startups
    • Search
    • News
  • opportunities
  • MIT ILP
  • Twitter
  • YouTube
  • LinkedIn
Home

1 Main Street
12th Floor, E90-1201
Cambridge, MA 02142


Accessibility

Privacy Policy

617-253-2691
startupexchange@mit.edu

Office of Corporate Relations